Portfolio Notes: Track, journal, and analyze every trade

CAMP4 Therapeutics

Contributing Author

Recent Articles by CAMP4 Therapeutics

Mar-24	CAMP4 Appoints Michael MacLean to its Board of Directors CAMP GlobeNewswire
Mar-06	CAMP4 to Participate in Upcoming Investor Conferences CAMP +49.40% CAMP -8.50% GlobeNewswire
Mar-05	CAMP4 Reports Full Year 2025 Financial Results and Corporate Highlights CAMP +12.50% GlobeNewswire
Feb-20	CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) CAMP GlobeNewswire
Jan-16	CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) CAMP -21.00% CAMP GlobeNewswire
Jan-06	CAMP4 to Present at the 44th Annual J.P. Morgan Healthcare Conference CAMP GlobeNewswire
Dec-18	CAMP4 Announces Pricing of $30.0 Million Underwritten Offering of Common Stock CAMP -12.90% GlobeNewswire
Dec-18	CAMP4 and GSK Enter Strategic Collaboration to Advance RNA-Based Therapeutic Discoveries CAMP -12.90% GlobeNewswire
Dec-12	CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) CAMP +7.99% GlobeNewswire
Nov-14	CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) CAMP GlobeNewswire
Nov-06	CAMP4 Reports Third Quarter 2025 Financial Results and Corporate Highlights CAMP +6.97% GlobeNewswire
Oct-01	CAMP4 Therapeutics Initiates GLP Toxicology Studies for CMP-SYNGAP-01 CAMP GlobeNewswire
Sep-10	CAMP4 Announces an Oversubscribed Private Placement of up to $100 Million to Advance First-in-Class Treatment for SYNGAP1-Related Disorders CAMP +40.20% GlobeNewswire
Aug-14	CAMP4 Reports Second Quarter 2025 Financial Results and Corporate Highlights CAMP +7.74% CAMP +6.16% GlobeNewswire
May-16	CAMP4 Presents Translational Data from SYNGAP1-Related Disorders Program Showcasing Increased Protein in Non-Human Primates and Reviews Preclinical and Detailed Single Ascending Dose Safety Data from Urea Cycle Disorders Program at the 28th American Society of Gene and Cell Therapy Annual Meeting CAMP +9.52% GlobeNewswire
May-13	CAMP4 Reports First Quarter 2025 Financial Results and Corporate Highlights CAMP -7.92% CAMP GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)